TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,572
|
1,383
|
2,826 |
Financial expenses |
695
|
193
|
283 |
Earnings before taxes |
-891
|
50
|
794 |
EBITDA |
-355
|
146
|
1,005 |
Total assets |
6,500
|
4,233
|
4,669 |
Current assets |
6,457
|
4,193
|
4,628 |
Current liabilities |
5,181
|
2,169
|
2,582 |
Equity capital |
1,319
|
2,064
|
2,087 |
- share capital |
101
|
95
|
98 |
Employees (average) |
2
|
3
|
4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.3%
|
48.8%
|
44.7% |
Turnover per employee |
786
|
461
|
706 |
Profit as a percentage of turnover |
-56.7%
|
3.6%
|
28.1% |
Return on assets (ROA) |
-3.0%
|
5.7%
|
23.1% |
Current ratio |
124.6%
|
193.3%
|
179.2% |
Return on equity (ROE) |
-67.6%
|
2.4%
|
38.0% |
Change turnover |
91
|
-1,358
|
-169 |
Change turnover % |
6%
|
-50%
|
-6% |
Chg. No. of employees |
-1
![]() |
-1
|
0 |
Chg. No. of employees % |
-33%
|
-25%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.